BioSimulytics

BioSimulytics provides a physics-based crystal structure prediction platform called CHEMINA™ to identify and rank solid forms of active pharmaceutical ingredients from 2D chemical diagrams. The technology helps pharmaceutical development teams, CROs, and CDMOs assess polymorph risks, inform formulation decisions, and protect intellectual property early in the drug development lifecycle. The company offers rapid preclinical risk assessments to map molecular landscapes and reduce the need for resource-intensive experimental screening.